Leva brings 20 years of broad commercial expertise to Exothera from a range of experiences with CDMOs, therapeutics, and software companies. Exothera S.A. , a full-service Contract Development and Manufacturing Organization (CDMO), has appointed Darren Leva as Chief Business Officer. Leva’s extensive commercial experience in biotherapeutics CDMOs will further extend Exothera’s business and commercial capability across existing and brand-new markets. Experience Leva brings 20 years of broad commercial expertise to Exothera from a range of experiences with CDMOs, therapeutics, and software companies. Most recently, he held leadership positions in Cell and Gene Therapy at Thermo Fisher Scientific while also being deeply involved in the manufacturing response to the Covid-19 pandemic. As Head of Commercial Operations, he helped build and lead both GMP Plasmid and GMP Cell Therapy businesses. Leva’s diverse experiences in the software industry have helped him develop a deep understanding of data-driven processes, which, combined with Univercells’ unique technologies and bioprocessing capabilities, will help Exothera realize its vision of making cell & gene therapy available to all. Prior to joining Thermo Fisher, Leva held various commercial roles at several start-ups and growth-stage companies, including IntroMaps, Althea Technologies (now Ajinomoto), Cerimon Pharmaceuticals, and Seven Bridges Genomics. In his […]
Click here to view original web page at www.contractpharma.com
